CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 28, 2011--
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced that Tuan
Ha-Ngoc, president and chief executive officer, is scheduled to present
at the 30th Annual J.P. Morgan Healthcare Conference onTuesday, January 10, 2012 at 11:30 a.m. (PST) at the Westin St. Francis
Hotel in San Francisco.
A live webcast of AVEO’s presentation can be accessed by visiting the
investors section of the company’s website at investor.aveopharma.com. A
replay of the webcast will be archived on the AVEO website for two weeks
following the presentation.
AVEO Pharmaceuticals (NASDAQ: AVEO) is a cancer therapeutics company
committed to discovering, developing and commercializing targeted
therapies to impact patients’ lives. AVEO’s proprietary Human Response
Platform™ provides the company unique insights into cancer biology and
is being leveraged in the discovery and clinical development of its
cancer therapeutics. For more information, please visit the company’s
website at www.aveopharma.com.
Source: AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc.
Caton Lovett, 910-232-7166